top of page

Recent Posts

MBNL1 was identified as a potential cancer drug target for a type of childhood leukemia

30 minutes ago
1 min read

Scientists found that the protein promotes survival of KMT2A-rearranged leukemia, presenting a previously unappreciated vulnerability.

Read more: https://www.stjude.org/media-resources/news-releases/2026-medicine-science-news/mbnl1-identified-as-potential-cancer-drug-target-for-type-of-childhood-leukemia.html

Comments

MBNL1 was identified as a potential cancer drug target for a type of childhood leukemia

What Limits Pediatric Oncology Trial Access for Marginalized Families?

Biochemists discover new strategy to combat pediatric bone cancer

Few Young Adults Receive Palliative Care as Part of Advanced Cancer Treatment

A childhood cancer faces a new enemy: this mRNA vaccine isn’t for viruses

Mental distress, fatigue common in childhood survivors of leukemia, lymphoma

Chemotherapy leaves early genomic fingerprints in childhood tumors

Targeting RBM5 may help disrupt ‘undruggable’ MYC in childhood leukemia

Ewing Sarcoma Survivors Experience Elevated Long-Term Health and Mortality Risks

New autologous T cell therapy offers hope for children with brain tumors

Archive

Search By Tags

bottom of page